Pharmacovigilance in Israel – tools, processes, and actions

Abstract Background Due to the limited safety data available at the time that a new medication is first marketed, it is essential to continue the collection and monitoring of safety data about adverse drug reactions (ADRs) during the medication’s life cycle. This activity, known as pharmacovigilance...

Full description

Bibliographic Details
Main Authors: Eyal Schwartzberg, Matitiahu Berkovitch, Dorit Dil Nahlieli, Joseph Nathan, Einat Gorelik
Format: Article
Language:English
Published: BMC 2017-08-01
Series:Israel Journal of Health Policy Research
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13584-017-0154-3